As of November 7, 2026, Microbot Medical Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 7, 2026 (Form 8-K, August 7, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Microbot Medical Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Microbot Medical Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-07. Every row below is cited to the filing it comes from, and this page adds each new change as Microbot Medical Inc. files it.
Also on the record for Microbot Medical Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| January 23, 2026 | Stake report, Schedule 13G, by Mitchell P. Kopin | 8.2% of the class | 5%+ stakes | Source |
| November 7, 2025 | Stake report, Schedule 13G/A, by Mitchell P. Kopin | — | 5%+ stakes | Source |
| October 31, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 4.45% of the class | 5%+ stakes | Source |
| September 30, 2025 | Form D, private offering | $25.24M sold | Form D page | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by Mitchell P. Kopin | 9.99% of the class | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G, by The Vanguard Group | 5.63% of the class | 5%+ stakes | Source |
| February 18, 2025 | Form D, private offering | $13M sold | Form D page | Source |
| January 22, 2025 | Form D, private offering | $7M sold | Form D page | Source |
| January 22, 2025 | Form D, private offering | $8.60M sold | Form D page | Source |
Selling to them or working with them? See who runs Microbot Medical Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Microbot Medical Inc. and the records around it.
Microbot Medical Inc. elsewhere on the record
- Form D filing Sep 2025
- Who owns it
Companies that share a holder
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Microbot Medical Inc.
Get an email when Microbot Medical Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Microbot Medical Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Microbot Medical Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Microbot Medical Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-07 | Reported | not named in the filing | 8-K, 2026-08-07 |
New leaders reset buying decisions — get the Full Report on Microbot Medical Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Microbot Medical Inc., with the record behind each one.
Find candidates like senior executive at Microbot Medical Inc.Every change, in the filing's words
Reported
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- On August 6, 2026, Microbot Medical Inc. (the "Company") entered into Addendum #4 to Employment Agreement (the "Addendum"), with Rachel Vaknin, the Company's Chief Financial Officer, to increase Ms. Vaknin's annual base salary to NIS 864,000 (the equivalent of $288,000 at a presumed 3:1 exchange rate of NIS to US Dollar), commencing as of August 1, 2026.
Tools for this story
Each opens in a new tab, filled in for Microbot Medical Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.